Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.43)
# 924
Out of 4,748 analysts
430
Total ratings
36.53%
Success rate
8.19%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEXX Lexaria Bioscience | Maintains: Buy | $10 → $7 | $1.81 | +286.74% | 5 | Jan 24, 2025 | |
| SMTI Sanara MedTech | Reiterates: Buy | $50 | $36.31 | +37.70% | 2 | Jan 23, 2025 | |
| RGNX REGENXBIO | Reiterates: Buy | $36 | $7.52 | +378.72% | 8 | Jan 15, 2025 | |
| CDNA CareDx | Reiterates: Neutral | $26 | $22.56 | +15.25% | 10 | Jan 14, 2025 | |
| BRNS Barinthus Biotherapeutics | Maintains: Buy | $5 → $3 | $0.95 | +215.79% | 12 | Jan 13, 2025 | |
| ANGO AngioDynamics | Maintains: Buy | $14 → $15 | $12.46 | +20.39% | 9 | Jan 10, 2025 | |
| OPK OPKO Health | Maintains: Buy | $3 | $1.50 | +100.00% | 10 | Jan 8, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $30 | $22.15 | +35.44% | 12 | Jan 6, 2025 | |
| VERU Veru Inc. | Reiterates: Buy | $3 | $0.61 | +390.84% | 20 | Jan 2, 2025 | |
| BLCO Bausch + Lomb | Reiterates: Buy | $23 | $17.88 | +28.64% | 15 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $16.33 | +200.06% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $8.27 | +105.56% | 20 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.73 | +184.61% | 20 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $7.84 | +91.33% | 25 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.23 | +103.25% | 19 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.05 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.65 | +146.58% | 16 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.00 | +133.33% | 17 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $6.70 | +64.18% | 17 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $8.83 | +69.88% | 19 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $5.43 | +157.83% | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.92 | +552.39% | 18 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $100 | $57.40 | +74.22% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.95 | +153.16% | 15 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.72 | +109.79% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1.5 | $0.79 | +89.47% | 22 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.17 | +156.41% | 1 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.07 | +554.21% | 9 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $13.25 | +186.79% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $1.5 | $0.17 | +774.13% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.62 | +1,512.90% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.45 | +2,355.36% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.99 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $0.78 | +22,947.38% | 1 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $19.63 | +144.52% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.04 | +21,405.38% | 5 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $11.46 | +65.79% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.31 | - | 2 | Apr 16, 2020 |
Lexaria Bioscience
Jan 24, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.81
Upside: +286.74%
Sanara MedTech
Jan 23, 2025
Reiterates: Buy
Price Target: $50
Current: $36.31
Upside: +37.70%
REGENXBIO
Jan 15, 2025
Reiterates: Buy
Price Target: $36
Current: $7.52
Upside: +378.72%
CareDx
Jan 14, 2025
Reiterates: Neutral
Price Target: $26
Current: $22.56
Upside: +15.25%
Barinthus Biotherapeutics
Jan 13, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.95
Upside: +215.79%
AngioDynamics
Jan 10, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $12.46
Upside: +20.39%
OPKO Health
Jan 8, 2025
Maintains: Buy
Price Target: $3
Current: $1.50
Upside: +100.00%
Oculis Holding AG
Jan 6, 2025
Reiterates: Buy
Price Target: $30
Current: $22.15
Upside: +35.44%
Veru Inc.
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.61
Upside: +390.84%
Bausch + Lomb
Dec 12, 2024
Reiterates: Buy
Price Target: $23
Current: $17.88
Upside: +28.64%
Dec 11, 2024
Reiterates: Buy
Price Target: $49
Current: $16.33
Upside: +200.06%
Dec 6, 2024
Reiterates: Buy
Price Target: $17
Current: $8.27
Upside: +105.56%
Dec 5, 2024
Reiterates: Buy
Price Target: $22
Current: $7.73
Upside: +184.61%
Dec 3, 2024
Reiterates: Buy
Price Target: $15
Current: $7.84
Upside: +91.33%
Nov 27, 2024
Reiterates: Buy
Price Target: $2.5
Current: $1.23
Upside: +103.25%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.05
Upside: -
Nov 22, 2024
Reiterates: Buy
Price Target: $9
Current: $3.65
Upside: +146.58%
Nov 19, 2024
Reiterates: Buy
Price Target: $7
Current: $3.00
Upside: +133.33%
Nov 18, 2024
Maintains: Buy
Price Target: $10 → $11
Current: $6.70
Upside: +64.18%
Nov 15, 2024
Reiterates: Buy
Price Target: $15
Current: $8.83
Upside: +69.88%
Nov 15, 2024
Reiterates: Buy
Price Target: $14
Current: $5.43
Upside: +157.83%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.92
Upside: +552.39%
Nov 13, 2024
Maintains: Buy
Price Target: $60 → $100
Current: $57.40
Upside: +74.22%
Nov 12, 2024
Reiterates: Buy
Price Target: $10
Current: $3.95
Upside: +153.16%
Nov 11, 2024
Reiterates: Buy
Price Target: $12
Current: $5.72
Upside: +109.79%
Nov 11, 2024
Reiterates: Neutral
Price Target: $1.5
Current: $0.79
Upside: +89.47%
Nov 7, 2024
Initiates: Buy
Price Target: $3
Current: $1.17
Upside: +156.41%
Oct 24, 2024
Reiterates: Buy
Price Target: $7
Current: $1.07
Upside: +554.21%
Aug 23, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $13.25
Upside: +186.79%
Jun 10, 2024
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.17
Upside: +774.13%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.62
Upside: +1,512.90%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.45
Upside: +2,355.36%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.99
Upside: -
May 19, 2022
Maintains: Buy
Price Target: $240 → $180
Current: $0.78
Upside: +22,947.38%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $19.63
Upside: +144.52%
Apr 1, 2021
Maintains: Buy
Price Target: $6 → $8
Current: $0.04
Upside: +21,405.38%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $11.46
Upside: +65.79%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.31
Upside: -